CJC-1295 (DAC Modification)
Long-acting, albumin-binding GHRH analog. DAC-modified 30-mer.
Endocrine & Cell Repair Research Peptides
IGF-1 LR3 is an engineered analog of human insulin-like growth factor-1 carrying an N-terminal methionine extension and an Arg³ substitution that confers resistance to IGF-binding proteins, increasing bioavailable exposure relative to native IGF-1. It is studied as an IGF-1-receptor agonist for cell-proliferation, anabolic-signaling, and cell-culture-supplementation research.
Research Use Only · Buyer verification required
Specifications
Documentation & Quality
Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.
Request a QuoteRequest a Quote
Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.
Long-acting, albumin-binding GHRH analog. DAC-modified 30-mer.
N-terminal 1–29 fragment of human GHRH. Shortest fully active form.
44-mer GHRH(1-44) analog with N-terminal hexenoyl cap.